AzTrials
AzTrials

FatigueNCT05346432

Effects of Lactobacillus Paracasei PS23 on Anti-fatigue

A study testing PS23 in people with Fatigue, run by Chi-Chang Huang at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research is to explore the effects of supplementing Lactobacillus paracasei PS23 to reduce fatigue and improve physical fitness after exhaustive exercise. Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Fatigue
What is being tested?
PS23
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
120 participants
Where
1 siteTaiwan
Study dates
1 May 2022to 10 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy adult men and women aged 20-40 who are generally non-athletic players

Who cannot join

  • BMI≧27
  • Known allergy to probiotics
  • Have current or history of inflammatory bowel disease
  • Patients using of other probiotic products (sachet, capsule or tablet) within the preceding two weeks
  • Those who have taken medication such as anti-inflammatory pain killer or antibiotics in the past one month
  • smoker and alcoholic
Show all 10Show fewer
  • Who have been injured within 6 months
  • Who has been diagnosed and treated of cardiovascular disease, hypertension, metabolic disease, asthma, or cancer
  • Have undergone surgery of liver, bladder, or gastrointestinal tract
  • Who has conflict of interest with PI

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • National Taiwan Sport University

    Taoyuan, 333

Other trials in Taiwan

About this study

This research is to explore the effects of supplementing Lactobacillus paracasei PS23 to reduce fatigue and improve physical fitness after exhaustive exercise.

Read the detailed description

Studies have found that the intestinal flora of athletes is different from that of ordinary people, and short-chain fatty acids play a very important role. Previous animal experiments have found that supplementing with specific probiotics can slow down muscle loss in aging mice. In addition, clinical studies have found that supplementing with probiotics can improve sports performance by regulating the intestinal flora and related metabolites. Therefore, the purpose of this research is to explore the effects of supplementing Lactobacillus paracasei PS23 to reduce fatigue and improve physical fitness after exhaustive exercise. This study compares supplementary samples with placebo and adopts a double-blind study design.

Conditions
Fatigue
Being tested
PS23
Medical subject headings
Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PS23Dietary supplement

    PS23 belongs to Lactobacillus paracasei group.Probiotic capsules contain 10 billion CFU (colony forming units) of PS23

Study groups in NCT05346432
Study groupRoleWhat they receive
PS23ExperimentalThe PS23 belongs to Lactobacillus paracasei group, 2 caps daily use.
Receives: Dietary Supplement: PS23
heat-treated PS23ExperimentalPS23 heat-treated, 2 caps daily use.
Receives: Dietary Supplement: PS23
placeboPlacebo comparatorThe placebo capsule contains microcrystalline cellulose, 2 caps daily use.
Receives: Dietary Supplement: PS23

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stress assessment - difference of Testosterone level

    To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, including baseline (0) and 3h, 24h, and 48 after exercise, blood samples were collected with brachial venous catheters. Used commercial kit human Testosterone (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis Male 265-923 (in ng/dl) Female 15-70 (in ng/dl) for 19 years and older

    Measured: From Baseline to 6 Weeks Assessed

  2. Difference in Clinical Biochemistry of CK level

    To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, blood samples were collected with brachial venous catheters. Assess serum CK(Creatine Kinase, U/L) to monitor physiological fitness. Serum CK (U/L), were assessed for monitoring physiological adaptation. All biochemical indices were assessed using an autoanalyzer (Hitachi 7060, Tokyo, Japan).

    Measured: From Baseline to 6 Weeks Assessed, including baseline (0) and 3h, 24h, and 48 after exercise

  3. Difference of Muscle damage - blood level of myoglobin

    To assess Muscle damage such as myoglobin (Female:14.3~65.8, Male:17.4~105.7) Volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, blood samples were collected with brachial venous catheters. Used commercial kit human myoglobin (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis

    Measured: From Baseline to 6 Weeks Assessed, including baseline (0) and 3h, 24h, and 48 after exercise

  4. Oxidative stress assessment - blood of MDA level

    comparing blood levels of oxidative markers such as Malondialdehyde (MDA)

    Measured: From Baseline to 6 Weeks Assessed

  5. Difference in Oxidative stress - blood level of CRP

    To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, blood samples were collected with brachial venous catheters. Used commercial kit human CRP (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis

    Measured: From Baseline to 6 Weeks Assessed, including baseline (0) and 3h, 24h, and 48 after exercise

  6. The Countermovement Jump (CMJ) Test

    The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The average power (MF), were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.

    Measured: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.

  7. The Countermovement Jump (CMJ) Test

    The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The peak power (Fpeak), were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.

    Measured: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.

  8. The Countermovement Jump (CMJ) Test

    The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. flight time (FT) were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.

    Measured: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.

  9. The Countermovement Jump (CMJ) Test

    The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The strength development speed (30 ms) were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.

    Measured: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.

  10. Wingate Anaerobic Test (WAnT)

    After a standard warm-up, all subjects were assessed with the classical WAnT on a cycloergometer (Monark 894E, Varberg, Sweden) in a 30 s "go all out" ultramax test. The seat height was adjusted to the satisfaction of each participant, and toe clips prevented the feet from slipping off the pedals. Before the initial test, the subjects warmed up for 5 min, and the power was approximately 50 W. After the warm-up, two preparation exercises lasting 3 s, during which the actual test load was 3% of their own body weight, were applied to accustom the participant to resistance. The test started, and the resistance was set on the friction belt of the dynamometer. External loading was estimated individually at 5% body weight. The recorded results were the relative mean power (W/kg), relative peak power (W/kg), and fatigue index (%). This assessment was performed before and 24 and 72 h after the exhaustive exercise program.

    Measured: From Baseline to 6 Weeks Assessed

  11. Isometric Mid-Thigh Pull (IMTP)

    Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak force (PF), relative peak force (N/Kg), rate of force development (RFD), peak rate of force development (pRFD), time to peak force (TPF) and time to peak rate of force development (TPRFD) parameters were recorded. This assessment was performed before and 24 and 48h after the exhaustive exercise program.

    Measured: From Baseline to 6 Weeks Assessed

  12. Isometric Mid-Thigh Pull (IMTP)

    Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak force (PF) were recorded.

    Measured: From Baseline to 6 Weeks Assessed. This assessment was performed before and 24 and 48h after the exhaustive exercise program.

  13. Isometric Mid-Thigh Pull (IMTP)

    Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak rate of force development (RFD) parameters were recorded.

    Measured: From Baseline to 6 Weeks Assessed. This assessment was performed before and 24 and 48h after the exhaustive exercise program.

Secondary outcomes (16)
  1. Gut microbiota

    Collect the DNA of fecal flora to test the diversity and abundance of gut microbiota in Stool samples before and after probiotics

    Measured: From Baseline to 6 Weeks Assessed

  2. Change in Perceived Stress Scale (PSS) Score From Baseline to Change in Perceived Stress Scale (PSS)

    The PSS scores is a rating tool used to gauge the course of stree. The minimum total score possible is 0 and the maximum total score possible is 40. Higher values represent a worse outcome.

    Measured: From Baseline to 6 Weeks Assessed

  3. Differences in the The Profile of Mood States (POMS) before and after probiotics consumption

    The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states. The Chinese version POMS measures six different dimensions of mood swings over a period of time. These include: Tension or Anxiety, Anger or Hostility, Vigor or Activity, Fatigue or Inertia, Depression or Dejection, Confusion or Bewilderment. A four-point scale ranging from "not at all" to "extremely" is administered by experimenters to patients to assess their mood states.

    Measured: From Baseline to 6 Weeks Assessed

  4. The Quality of Life, Enjoyment, and Satisfaction Questionnaire-16, QLESQ-16

    The Quality of Life, Enjoyment, and Satisfaction Questionnaire-16 (QLESQ-16) is a valid, reliable self-report instrument for assessing quality of life.

    Measured: From Baseline to 6 Weeks Assessed

  5. Visual Analogue Scale-GI (VAS-GI)

    Visual Analogue Scale (VAS) consists of a line, 10 cm in length. Individuals point to or mark a spot on the line where they feel indicates their current their emotion, fatigue level and sleep quality. The score of emotion level is from 0cm (very nervous) to 10 cm (very relaxing). The score of fatigue level is from 0 cm (very energetic) to 10 cm (very sleepy). The score of sleep quality is from 0 cm (poor) to 10 cm (sleep well). The maximum total score is 100% (equal 10cm).

    Measured: From Baseline to 6 Weeks Assessed

  6. Change in Patient Global Impression of Change (PGIC)

    The PGIC consists of one item taken from the clinical global impression and adapted to the patient. The minimum total score possible is 1 and the maximum total score possible is 7. Higher values represent a worse outcome.

    Measured: From Baseline to 6 Weeks Assessed

  7. Safety assessment - AST

    Safety is assessed function of liver and kidney such as AST (8-38 IU/L).

    Measured: From Baseline to 6 Weeks Assessed

  8. Safety assessment - ALT

    Safety is assessed function of liver and kidney such as ALT (4-44 IU/L).

    Measured: From Baseline to 6 Weeks Assessed

  9. Safety assessment - T-Cholesterol

    Safety is assessed function of liver and kidney such as T-Cholesterol (<170 mg/dL).

    Measured: From Baseline to 6 Weeks Assessed

  10. Safety assessment - Uric Acid

    Safety is assessed function of liver and kidney such as Uric Acid (3.4-7.6 mg/dl)

    Measured: From Baseline to 6 Weeks Assessed

  11. Safety assessment - Bun

    Safety is assessed function of liver and kidney such as Bun (6-20 mg/dl)

    Measured: From Baseline to 6 Weeks Assessed

  12. Safety assessment - Creatinine

    Safety is assessed function of liver and kidney such as Creatinine (0.6-1.3 mg/dl)

    Measured: From Baseline to 6 Weeks Assessed

  13. Safety assessment - Glucose

    Safety is assessed function of liver and kidney such as Glucose (70~100 mg/dL)

    Measured: From one week before Baseline to 6 Weeks Assessed

  14. Safety assessment - Triglycerides

    Safety is assessed function of liver and kidney such as Triglycerides (<150 mg/dL)

    Measured: From Baseline to 6 Weeks Assessed

  15. Safety assessment - LDL

    Safety is assessed function of liver and kidney such as LDL (0~140mg/dl)

    Measured: From Baseline to 6 Weeks Assessed

  16. Safety assessment - HDL

    Safety is assessed function of liver and kidney such as HDL (>40mg/dl)

    Measured: From Baseline to 6 Weeks Assessed

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2022
  2. Study start1 May 2022
  3. Primary completion10 Jul 2022
  4. Study completion10 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05346432
Sponsor's protocol ID
22-003-A2
Status last verified
Jul 2022
First submitted
24 Mar 2022
Last updated
12 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing PS23 in people with Fatigue, run by Chi-Chang Huang at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stress assessment - difference of Testosterone level (time frame: From Baseline to 6 Weeks Assessed). The study lists 13 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in